Martha T. Castaneda CATC

Recommended Articles

• Morphos Declared a "Breakthrough Therapy" for Lymphoma

  MorphoSys’s main objective is to design exceptional and unique biopharmaceuticals, all designed to enhance the lives of patients suffering from severe or life-threatening conditions.The human body has two types of lymphocytes that can develop into lymphomas: B lymphocytes (B cells) and T...

• Bronchitis: The Complications

  Bronchitis can cause several other complications to arise if the condition worsens.AsthmaAsthma may put an effect on an individual’s performance at the workplace or at school. Children may miss school or college as a result of the difficulty in breathing. The lungs can become either partially or...

• This Drug Significantly Stops Cell Growth in Metastatic Breast Cancer

  HER2-negative metastatic breast cancer is a common yet incurable disease that has spread from the breast to other parts of a person’s body. It’s an aggressive cancer that usually affects the breast plus a patient's bone, lungs, liver and brain. Even when breast cancer spreads into other parts of...

• What is Testicular Cancer: Get the Facts

  Testicular cancer is a malignancy that affects the testes, which are the sex glands in men that are responsible for secreting the male sex hormone testosterone and for producing sperm cells that fertilize female eggs to kick start a pregnancy.Prevalence of testicular cancerIn the United States,...

• How is Metabolic Syndrome Treated?

  Metabolic syndrome refers to the presence of several conditions, including high blood pressure, high blood sugar levels, abdominal fat, and elevated cholesterol levels, which increases the risk for heart disease and stroke. The risk of serious diseases increases considerably with any of the...

• Ovarian Cancer Vaccine Development: An Update

  OncBioMune Pharmaceuticals, a clinical-stage bio-pharmaceutical company, is advancing its developments in vaccine technology to help boost the immune system to target cancer cells without causing harm to the patient. They have worked on prostate cancer vaccines and are working on ovarian cancer...